SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-18-000012
Filing Date
2018-05-09
Accepted
2018-05-09 17:20:48
Documents
67
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgen-03312018x10q.htm 10-Q 968367
2 EXHIBIT 10.1 mgen-03312018xex101.htm EX-10.1 39035
3 EXHIBIT 31.1 mgen-03312018xex311.htm EX-31.1 12676
4 EXHIBIT 31.2 mgen-03312018xex312.htm EX-31.2 12784
5 EXHIBIT 32.1 mgen-03312018xex321.htm EX-32.1 15066
  Complete submission text file 0001590750-18-000012.txt   4720103

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mgen-20180331.xml EX-101.INS 679788
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgen-20180331.xsd EX-101.SCH 45646
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgen-20180331_cal.xml EX-101.CAL 60297
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgen-20180331_def.xml EX-101.DEF 240822
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgen-20180331_lab.xml EX-101.LAB 564793
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgen-20180331_pre.xml EX-101.PRE 336065
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 18819513
SIC: 8071 Services-Medical Laboratories